NDTVCenter·
Natco Pharma Shares Gain After US FDA Tentative Approval for Generic Cancer Drug
Natco Pharma shares are in focus after receiving tentative US FDA approval for generic Olaparib tablets.
Read at NDTV →
Business · 1 sources covering this
Natco Pharma Shares Gain After US FDA Tentative Approval for Generic Cancer Drug
Natco Pharma shares are in focus after receiving tentative US FDA approval for generic Olaparib tablets.
Coverage spectrum
0 L · 1 C · 0 R
How 1 sources are covering this
Embed this bias spectrum on your site
Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.
<iframe src="https://hindustansphere.com/embed/cluster/c461178d260c3ef543415c234fc478b7634a98aa" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Natco Pharma Shares Gain After US FDA Tentative Approval for Generic Cancer Drug"></iframe>
